ACAT2 and metabolic dysfunction-associated steatotic liver disease: Since FC rather than total cholesterol contributes to the progression of NAFLD (3), we induced FC overload in Huh7 cells by treatment with cholesterol and 58035, an inhibitor of acetyl-CoA acetyltransferase 2, a liver-specific enzyme responsible for the conversion of FC to cholesterol ester (3).